Adrenal Cushing’s Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy

Background/Objective: Reducing severity of Cushing’s syndrome caused by an adrenal adenoma (adrenal Cushing’s syndrome [ACS]) might decrease morbidity and mortality risk in adrenalectomy. We used off-label osilodrostat, approved in the United States for pituitary Cushing’s disease, to reduce cortiso...

Full description

Bibliographic Details
Main Authors: Risha B. Malik, MD, Anat Ben-Shlomo, MD
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:AACE Clinical Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060522000657